Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection

NCT01032655 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT01032655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01032655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2009
Completion date
March 31, 2012
Enrollment
134 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection